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Abstract
Interferon lambda 4 gene (IFNL4) encodes IFN-l4, a new member of the IFN-l family with antiviral activity. In humans IFNL4
open reading frame is truncated by a polymorphic frame-shift insertion that eliminates IFN-l4 and turns IFNL4 into a
polymorphic pseudogene. Functional IFN-l4 has antiviral activity but the elimination of IFN-l4 through pseudogenization is
strongly associated with improved clearance of hepatitis C virus (HCV) infection. We show that functional IFN-l4 is
conserved and evolutionarily constrained in mammals and thus functionally relevant. However, the pseudogene has
reached moderately high frequency in Africa, America, and Europe, and near fixation in East Asia. In fact, the
pseudogenizing variant is among the 0.8% most differentiated SNPs between Africa and East Asia genome-wide. Its raise in
frequency is associated with additional evidence of positive selection, which is strongest in East Asia, where this variant falls
in the 0.5% tail of SNPs with strongest signatures of recent positive selection genome-wide. Using a new Approximate
Bayesian Computation (ABC) approach we infer that the pseudogenizing allele appeared just before the out-of-Africa
migration and was immediately targeted by moderate positive selection; selection subsequently strengthened in European
and Asian populations resulting in the high frequency observed today. This provides evidence for a changing adaptive
process that, by favoring IFN-l4 inactivation, has shaped present-day phenotypic diversity and susceptibility to disease.
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Introduction
Interferon-lambda (IFN-l) proteins induce antiviral effectors in
host target cells and have a crucial role in immune defense against
pathogens [1]. The IFNL family classically included three genes
(IFNL1, IFNL2, and IFNL3; formerly IL29, IL28A, IL28B,
respectively) located within a 50 kb region of chromosome 19
[2,3]. Several intergenic variants within the IFNL cluster had been
identified as showing remarkable association with clearance of
hepatitis C virus (HCV) [4–6], which is worldwide responsible for
,170 million infections and over 350,000 deaths per year [7,8].
The underlying functional basis of this association remained
unclear despite numerous efforts to identify functional conse-
quences of these variants [9–16].
An additional member of the IFN-l family has recently been
discovered: IFN-l4, which bears only 30% amino acid identity
with the other IFN-ls and is encoded by the IFNL4 gene, also
located within the IFNL locus [2,17]. IFN-l4 shows similar
antiviral activity like IFN-l3 but as it shows limited secretion it
might also act intracellularly, unlike the other IFN-ls [18]. A
compound di-nucleotide exonic variant (rs368234815, DG.TT)
in IFNL4 causes a frame-shift of its open reading frame and results
in the polymorphic pseudogenization of IFNL4 - the polymorphic
loss of IFN-l4 protein [17]. The existence of IFNL4 was not even
computationally predicted because the human reference genome
contains the TT allele and lacks the IFNL4 open reading frame
[17]. Remarkably, the derived TT allele not only eliminates IFN-
l4, but it also shows the strongest genetic association reported to
date with improved spontaneous and treatment-induced HCV
clearance [17,19,20].
The function of IFN-l proteins is crucial for response to
pathogens and this locus has evolved under natural selection, with
signatures of positive selection being described in the three
classical IFNL genes (IFNL1-3) [21]. However, that analysis did
not cover the IFNL4 gene, nor the frame-shift rs368234815
variant, which were then unknown [21]. Therefore, the
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evolutionary history of this interesting functional variant and its
influence on the local signatures of selection remained unknown.
Here we report an in-depth comparative and population genetic
analysis that focuses on IFNL4 and the rs368234815 polymorph-
ism. We show that the functional IFN-l4 protein is under
purifying selection in mammals, while in humans the IFNL4
pseudogenizing TT allele carries strong signatures of positive
selection. We use a new Approximate Bayesian Computation
(ABC) approach [22,23] to provide evidence of a complex selective
history of the TT allele, which involves changes in selective
strength across human populations. This selective process had
important implications in present-day phenotypic diversity and
susceptibility to disease.
Results
Functional IFN-l4 is strongly conserved in mammals
The IFNL4 gene is present in most mammals analyzed,
although it is absent in mouse and rat (Methods). To understand
the evolutionary conservation of IFNL4 we performed a
comparative analysis of the IFNL4 coding sequences from a
representative set of mammals (N= 12). The overall dN/dS (non-
synonymous to synonymous substitution ratio) is 0.23 across
mammals and 0.22 across primates (Figure 1), indicative of
purifying selection maintaining the sequence and function of the
protein. Notably, all individual branches except squirrel monkey
have dN/dS,1 and no model of protein evolution supported dN/
dS.1 in specific branches or sites (Table S1). This reveals strong
evolutionary conservation of IFN-l4 in mammals, reflecting its
functional relevance.
Strong population differentiation for the TT allele
The selective constraint on IFN-l4 contrasts with the
pseudogenization of the gene in humans through the derived
TT allele [17]. The multiple-species alignment shows that DG is
the conserved, ancestral allele and TT is the derived human-
specific allele. The mutational process from DG to TT in humans
is unclear, but only these two forms have been observed, so they
should be considered as two alleles of a di-nucleotide variant
(Methods). The TT allele shows considerable frequency variation
across human groups. The 1000 Genomes data [24] reveals a
gradient in frequency that rises from Africa (0.29–0.44) to Europe
(0.58–0.77) and the New World (0.51–0.65), and reaches near
fixation in East Asia (0.94–0.97) (Figure 2, Table S2, full
population names in Methods).
Population differentiation can be quantified with the fixation
index FST [25], a measure of the pairwise level of differentiation in
allele frequencies. We used Yoruba (YRI) as the background
population because it has the lowest frequency of the derived TT
allele in Africa. To put these values in the context of genome-wide
population differences, FST was also calculated for every SNP in
the 1000 Genomes dataset. For the TT allele the largest FST, 0.63,
corresponds to Southern Han Chinese (CHS) versus YRI, which
places the TT allele in the 0.5% tail of the empirical genomic
distribution of CHS-YRI FST (Fig. 3A, Table 1). FST is also in the
0.8% tail of the genomic distribution for the other East Asian
populations (CHB, JPT, Fig. 3B and C, Table 1), and in the 4%
tail for Europeans (CEU) and one African population, Luhya
(LWK) (Table 1, Fig. S1). These results remain significant when
other populations were used as background and in continental
comparisons, and when the genome-wide distribution was
restricted to SNPs with the lowest frequency in Yoruba (Table
S3). Therefore, rs368234815 is among the 0.8% most differen-
tiated SNPs between African and East Asians, and among the 12%
most differentiated SNPs between African and European popula-
tions.
The TT allele resides in a population-specific extended
haplotype
The unusually high population differentiation of the TT allele is
compatible with a scenario of recent population-specific natural
selection. Under certain selection models such high differentiation
should be accompanied by extended haplotype homozygosity in
the populations experiencing selection, but not in other popula-
tions. We evaluated such a signature with the cross population
extended haplotype homozygosity test [26] (XP-EHH), which was
calculated across the genome relative to the Yoruba population.
The XP-EHH value for the TT allele is in the 0.5% tail of the
empirical distribution for East Asian populations (p = 0.003, 0.005,
and 0.003, for CHS, CHB, and JPT, Fig. 3A–C, Table 1), and the
signal remains significant when calculated relative to a European
population (GBR) and in analyses at the continental level (Table
S4). In addition, some non-Asian populations show marginally
significant signatures of positive selection too (CEU, PUR, LWK,
Table 1, Fig. S1). Similar results were obtained with iHS, a
statistic that explores haplotype homozygosity within a single
population [27] (Table 1) (although iHS lacks power when
population frequency is very high, like in Asia). The unusual
allele-specific haplotype homozygosity is evident in Figure 3D,
which shows the haplotype structure of the locus in one African,
one European, and one East Asian population (for all populations
see Fig. S3). We note that FST shows very weak correlation with
both XP-EHH and iHS in the genome (r = 0.12 and r =20.08
Spearman rank test, respectively, although the large number of
data points makes these weak correlations significant, P-value,
2.2e-16). Therefore, the FST and XP-EHH/iHS observations can
be considered largely independent.
Finally, not only rs368234815 itself but also its genetic locus
shows signatures of recent positive selection, with significant Fay
and Wu’s H test [28] (FW), which detects an excess of high-
frequency derived alleles in the region (Table 1). Together, the
combined signatures of FST, XP-EHH, iHS and FW provide
strong evidence for the action of natural selection rapidly
Author Summary
The genetic association with clearance of Hepatitis C virus
(HCV) is one of the strongest and most elusive known
associations with disease. The genetic variant more
strongly associated with improved HCV clearance inacti-
vates the recently discovered IFNL4 gene, which encodes
for antiviral IFN-l4 protein, and turns it into a polymorphic
pseudogene. We show that functional IFN-l4 is conserved
and functionally important in mammals. In humans
though the inactivating mutation appeared in Africa just
before the out-of-Africa migration and quickly became
advantageous, with the strength of selection (the degree
of advantage) varying across human groups. In particular,
selection became stronger out of Africa and was strongest
in East Asia, raising the frequency of the pseudogene and
resulting in the virtual loss of functional IFN-l4 protein in
several Asian populations. Although the environmental
force driving selection is unknown, this process resulted in
variable clearance of HCV in modern human populations.
The complex selective history of IFNL4-inactivating allele
has thus shaped present-day heterogeneity across popula-
tions not only in genetic variation, but also in relevant
phenotypes and susceptibility to disease.
Local, Adaptive Pseudogenization of IFNL4
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increasing the frequency of the TT allele in East Asia. The
signature outside Asia is less clear, with most populations showing
significant signatures of selection for a subset of the tests
performed.
Cumulative evidence that TT allele drives the signatures
of selection
A classical problem in population genetics is the identification of
the genetic variant responsible for a selection signal. High linkage
disequilibrium (LD) in the region surrounding IFNL4 (Table 2,
Fig. 3D, Fig. 4, Fig. S7) hampers the distinction of signatures
across all the linked variants, making it difficult to identify the
causal variant. We conclude that rs368234815 is the most likely
variant driving the signatures of selection, based on three lines of
evidence: (1) its functionality and phenotypic consequences, (2) its
genetic association with viral clearance, which reflects its effect on
fitness, and (3) its signatures of selection.
First, the TT allele has a clear phenotypic consequence as it
leads to abrogation of IFN-l4. This is in contrast with other
variants in the locus for which no conclusive functional data has
been reported despite numerous efforts [9–14]. Second, of all
variants in the IFNL region, rs368234815 shows the strongest
genetic association with spontaneous and treatment-induced HCV
clearance in African Americans [17,19]; in Europeans and Asians
the strong LD across the region results in comparable associations
for many variants [15–17,20,29] (Table 2, Fig. S2, Fig. S7). Third,
of all protein-coding or HCV-associated variants in this locus,
rs368234815 shows the strongest combined signatures of positive
selection in East Asians (Fig. 3A–C, Fig. S1 and S2, Table 2).
Only one other polymorphism (intergenic rs8109886, located
upstream of IFNL4, Fig. 4), shows signals of selection comparable
to rs368234815 (Fig. S2, Table 2). No function has been ascribed
to this variant despite a moderate HCV association that is likely
due to linkage to TT [6,17,30] (Table 2 and Fig. 4), making it a
priori a less likely candidate for selection. Indeed, simulations of
the evolutionary process showed that the large frequency change
of rs8109886 can be explained by linkage to the TT allele alone
(Note S1).
We also put rs368234815 in the context of the signatures of
selection in the larger genomic region. IFNL4 is located upstream
of IFNL3 in a region of moderate LD that is separated from the
IFNL1/IFNL2 locus by a recombination hotspot (Fig. S7,
Table 2). Manry et al. [21] identified signatures of recent positive
selection in all three original IFNL genes (IFNL1-3) but neither
IFNL4 nor the rs368234815 variant were known at that time and
thus they were not considered. The recombination hotspot breaks
LD between the IFNL1/INFL2 locus and the IFNL3/IFNL4
locus (Fig. S7, Table 2), showing that these signatures are in all
likelihood independent, as suggested by Manry et al. [21]. There is
moderate LD between IFNL4 and IFNL3, with an average r2
Figure 1. Phylogenetic tree showing the dN/dS ratio of each lineage analyzed.
doi:10.1371/journal.pgen.1004681.g001
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PLOS Genetics | www.plosgenetics.org 3 October 2014 | Volume 10 | Issue 10 | e1004681
between rs368234815 and IFNL3 SNPs of 0.18 in CEU and of
0.44 in CHS (see also Fig. S7). So, the selection signatures in
IFNL3 and IFNL4 may not be independent. In fact, the seven
SNPs identified by Manry et al. [21] (detailed in Table 2 and
Fig. 4) have (1) weaker signatures of selection; (2) unclear
functional effects, and (3) weaker association with HCV clearance
than the TT allele in Africa (Table 2, Figure 4). Also, those that
show some signatures of selection have high to moderate LD with
rs368234815 (Table 2), with LD broken mostly by a few
recombination events in the ancestral haplotype (Note S1). Taken
together, these lines of evidence confirm that IFNL1/2 and
IFNL3/IFNL4 have likely been independently targeted by positive
selection in recent human history, as suggested by Manry et al.
[21], and highlight rs368234815 TT as the most likely selected
allele in its region.
Mode and tempo of positive selection on the TT allele
The classical model of positive selection involves selection on a
de novo mutation (SDN), a so-called hard sweep, where a new
mutation immediately becomes beneficial and selected (reviewed
in [31]). This scenario is difficult to reconcile with our
observations, because unequivocal signatures of selection are
observed only in East Asians but the TT allele is common
worldwide. The TT-carrying haplotype harbors the highest
genetic diversity in Africa indicating that it arose there before
the out-of-Africa dispersion (Note S2, Table S5), a result that is
consistent with the IFNL4 haplotype network (Fig. S4). Under
SDN, only a model where selection begins weak in Africa and
becomes stronger outside of Africa could explain our observations
(Fig. 5A). An alternative model is selection from standing variation
(SSV), also known as a soft sweep (reviewed in [31]). In this
scenario an existing neutral or nearly neutral allele becomes
advantageous, for example upon environmental change (Fig. 5A).
To disentangle the most likely model of selection for the TT
allele we applied a modified version of a recently published ABC
approach [23], which we extended to be able to analyze two-
population models. In brief, we match millions of simulations
under the different models to a summary of the observed genetic
data in the IFNL4 region, and use the best matching simulations
for further inferences. Under reasonable assumptions we expect
the most realistic selection model to produce the closest
simulations to real data, and thus simulations can be used to
make inferences about the selective history of the allele [23]
including the model of selection and relevant parameters (Note
S3). While the method relies on some assumptions (e.g. correct
demographic and dominance models) this approach has been
shown to be robust and to have high power to recover the correct
selection scenario [23]. We assess that we overall have high power
to recover the correct model, with 76% of the SSV and 95% of the
SDN simulations being assigned correctly under the East Asian
demographic model, and 70% of the SSV and 97% of the SDN
simulations being assigned correctly under the European demo-
graphic model (Note S3). The slight bias observed was considered
when interpreting the results. For our analysis we consider three
models: neutrality (no selection), selection from a de novo mutation
(SDN) and selection from standing variation (SSV) (Fig. 5A).
In East Asian populations we obtain negligible support for
neutrality and very strong support for the SDN model (Fig. 5B,
Table 3, Table S6). Results in Europeans are also consistent with
the SDN model, although the weaker signals of selection and the
slight bias observed above make these results less conclusive
(Table 3, Note S3, Fig. S5, Table S6). The posterior probability
Figure 2. Allele frequency of rs368234815 - DG allele (blue) and TT allele (green) for each population from the 1000 Genomes
dataset. American populations of European and African origin (CEU, ASW) are placed near the geographic area of origin. For full population names
see Methods.
doi:10.1371/journal.pgen.1004681.g002
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for the SDN model is ,95% in East Asia and ,80% in Europe,
corresponding to Bayes factors (Bayesian measures of relative
model support [32]) of ,10 and ,4, respectively. This provides
substantial and robust evidence for the SDN model, compared to
the SSV and NTR models for East Asian and European
populations according to Jeffrey’s interpretation [33]. Therefore,
we conclude that the TT allele was likely positively selected upon
appearance. The ABC-based parameter estimates are less
reliable than the model choice [23] because they always have
large credible intervals (Bayesian measures of confidence).
However, the posterior distributions have modes that differ
from the modes of the prior distributions, indicating that they are
determined by information from the data and not by the prior
(Fig. S5). Also, the estimates are quite concordant within and
between continental groups (Fig. S5, Table 3). So while they
should be interpreted with appropriate caution, the estimates do
provide additional useful information about the model and
timing of selection. We infer that the TT allele emerged before
the out-of-Africa migration (estimated tmut<55,900 years ago
(41,360–68,640)) and was immediately, or shortly thereafter,
targeted by moderate positive selection (selection coefficient, sA,
<0.58% (0.17–1.23)); we estimate that selection intensified
substantially outside of Africa, with the selection strength nearly
quadrupling in Europe and in Asia (sNA<2.6% (0.6–4.8);
Table 3, Fig. S5).
One important aspect of the simulations is the mode of
dominance (also known as the genetic model), and the ABC
analysis above was performed on simulations under a perfectly
additive model where heterozygotes have half the fitness effect of
homozygotes (dominance coefficient h = 0.5). This model is
reasonable because in TT/DG heterozygotes only one IFNL4
copy is truncated, and because genetic studies show that the odds
ratios (ORs) for HCV clearance in heterozygotes are intermediate
to those in the two homozygotes [17]. These two arguments argue
strongly against a model of complete dominance for TT as
realistic, but other models are more difficult to discard a priory.
We thus compare three dominance models: (1) a fully recessive
model for the TT allele (h = 0), (2) the perfectly additive model
used above (h= 0.5), and (3) a supra-additive model where the
additive effect is non-linear and heterozygotes are closest in fitness
to DG homozygotes. This model has been proposed based on the
ORs for the intronic IFNL4 variant, rs12979860 which is in high
LD with rs368234815 and is thus a good proxy for the dominance
effects of TT (Table 2) [34]. Based on those results we use a
Figure 3. Empirical P-values of the FST and XP-EHH analysis (depicted as dots or diamonds, respectively) in the 30 Kb genomic
locus around IFNL4 (chr19:39724153–39754153) for (A) CHS, (B) CHB, and (C) JPT using YRI as background. All XP-EHH values are
connected by a fitting curve (yellow line). The 1% tail of the genomic empirical distribution is indicated by the horizontal, dashed line. (d) Haplotype
structure in the same region as above, for an African (YRI), European (CEU), and East Asian (CHS) population. Columns represent SNPs with a derived
allele frequency .5% in at least one population (n = 99 SNPs), with the ancestral allele in white, and the derived allele in black. Lines represent the
haplotypes they fall in, as inferred with SHAPEIT by the 1000 Genomes consortium [24]. Haplotypes were sorted based on rs368234815 (red arrow)
and SNPs in perfect LD with it in CHS (black arrows); see also Table 2 and Figure 4. The bar on the left-hand side of each plot indicates the haplotypes
that carry the TT allele (red) or the DG allele (blue).
doi:10.1371/journal.pgen.1004681.g003
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dominance coefficient h = 0.38 (see Note S4). When we compare
the three dominance models in East Asia, regardless of the
selection model, the fully recessive model has marginal support
(4%), with the two additive models showing similar posterior
probabilities (slightly higher for additive: 56%, than supra-
additive: 44%, Fig. 5C and Note S4). When we compare the
ABC results in the two additive models, they both strongly support
the SDN model over the SSV model (95% in the additive model
and 90% in the supra-additive model, corresponding to a Bayes
factor of ,12), and both models provide virtually no support for
the neutral model (Figure 5B–D and Note S4). Parameter
estimates also agree well among these two models (Fig. S5, Fig.
S6 and Note S4). Therefore our results in East Asia validate the
use of an additive model and show that the ABC inferences are not
sensitive to the particularities of the additive model used. In
European population the results are less clear, just as in the
original ABC analysis and as expected given the weaker signatures
of selection. Still, these results also support the two additive models
(36% support for additive and 38% for supra-additive; Fig. 5C) as
well as the SDN model (,81% support for SDN in both the
additive and the supra-additive, corresponding to a Bayes factor
,4, Fig. 5B and D, Note S4).
These results show a complex selection history for the TT allele,
with selection starting upon appearance of the allele but with
intensity changing over time and geographic range. The model is
consistent with all our observations, including the marginal
evidence for selection observed in non-Asian populations (Ta-
ble 1). It is interesting that we infer selection on the TT allele even
in Yoruba, where the signature is undetectable with classical
methods likely because of weak selection and lower frequency
although the TT allele shows clear signatures of homozygosity
(Fig. 3D). Interestingly, and in agreement with this model, we do
observe some signatures of positive selection in another African
population, the Luhya. It remains possible that the advantage of
the TT allele was counteracted by additional selective forces in
Africa that maintained the TT allele at an intermediate frequency,
such as balancing selection, although we note that the locus lacks
classical signatures of long-standing balancing selection (Note S5,
Table S7).
Discussion
Here we show that functional IFN-l4 is under purifying
selection throughout the mammal clade while positive selection
has favored the elimination of IFN-l4 through pseudogenization
in humans. Selection on the TT allele has been particularly strong
in specific populations, leading to extremely high frequency of the
pseudogene and subsequent virtual loss of IFN-l4. This event is
phenotypically relevant: not only is IFN-l4 biologically important
[17,18] and evolutionary conserved, but the loss of IFN-l4
through pseudogenization shows remarkable association with
improved HCV clearance [17,19,20].
The precise reason behind the advantage of IFN-l4 elimination
is unknown, but its immunological role and clear antiviral activity
against HCV [17] make exposure to pathogens (and in particular
viral agents) the most likely selective force. However, due to its
slow progression into fatal disease [35] HCV is unlikely to have
exerted such strong selective pressure, although we cannot
completely discard this possibility. Besides HCV, it has been
shown that functional IFN-l4 has antiviral activity against
coronaviruses [18], while the IFN-l4 pseudogene increases
susceptibility to cytomegalovirus retinitis among HIV-infected
patients [36]. Suggesting that IFN-l4 pseudogenization is likely
associated with several phenotypic traits. It is perhaps surprising
that suppression of an antiviral protein results in improved viral
clearance, although it has for example been shown that during
chronic infection blockage of persistent signaling of IFN I (a
different type of interferon) can improve viral clearance [37,38].
We showed that a complex selective regime, with variation in
selection strength in different geographical areas, best explains the
history of the IFNL4 locus. Signatures of non-neutral evolution
have been detected in other interferons, including at least one
other IFNL family member (IFNL1 or IFNL2) [21]. Although the
mode and tempo of selection in these other IFNL genes are not
well understood, together these observations suggest that IFN-l
proteins have played an important role in recent human
adaptation, probably as a consequence of their role in individuals’
constant fight with pathogens. It is likely, though, that only the
selective history of the IFNL4-TT allele had a strong influence in
Table 1. FST values and for FST, XP-EHH, iHS and Fay and Wu’s H (FW) the empirical P-values are shown for rs368234815 in every
population.
Population FST FST P-value XP-EHH P-value iHS P-value FW P-value
CHS 0.63 0.005 0.003 -b 0.01
CHB 0.60 0.006 0.005 0.22 0.01
JPT 0.56 0.008 0.003 0.05 0.01
GBR 0.22 0.074 0.071 0.03 0.07
CEU 0.31 0.040 0.041 0.02 0.04
FIN 0.26 0.059 0.059 0.09 0.06
TSI 0.15 0.120 0.070 0.05 0.10
CLM 0.09 0.172 0.201 0.06 0.09
MXL 0.04 0.368 0.145 0.50 0.11
PUR 0.19 0.064 0.029 0.10 0.06
ASW 20.01 0.684 0.634 0.08 0.20
LWK 0.05 0.036 0.043 0.03 0.12
YRI -a -a -a 0.14 0.21
aFST and XP-EHH were not calculated for YRI, which is the background population.
biHS requires a MAF of 5%, which is not given for CHS.
doi:10.1371/journal.pgen.1004681.t001
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the rate of clearance of some viruses, at least HCV, across human
groups.
It has been proposed that gene loss may exert an important role
in evolution, including human evolution [39], and the loss of
otherwise conserved regulatory elements may play a role in the
acquisition of human-specific phenotypes [40]. Loss-of-function
mutations show global signatures of purifying selection [41–43]
and tend to carry detrimental effects [44]. A few exceptions exist,
though, where truncating polymorphisms show signatures of
positive or balancing selection [45–50]. Still, as with other targets
of selection, most of these cases lack biological interpretation. In
fact, IFNL4 joins a small group of known genes where a striking
signature of local adaptation is coupled with a clear molecular
phenotype (e.g. [46,47,51]), which in this case is also associated
with disease risk. As such, it contributes to our understanding of
how recent human evolution has shaped genetic and phenotypic
human diversity, including present-day heterogeneity in suscept-
ibility to disease.
Materials and Methods
Molecular Evolution of IFNL4 across species
In order to explore the level of functional constraint in IFNL4,
we estimated the level of protein conservation in primate and non-
primate mammals. Specifically, we assessed the ratio (dN/dS) of
non-synonymous substitutions per non-synonymous site (dN) to
synonymous substitutions per synonymous site (dS) across gene
orthologs. Since purifying selection eliminates deleterious protein-
coding changes, dN/dS decreases with negative selection and
increases with relaxed constraint and positive selection.
We used human IFNL4 reference sequence NM_001276254.2
to BLAT genomes of other species and generate multiple-species
sequence alignment of IFNL4 coding exons 1 through 5 (Table
S8). The panda-predicted IFNL4 ortholog was subsequently used
as BLAT query to extract coding exons for additional non-primate
species (Table S8). Further, we sequenced IFNL4 (exons and
introns) in genomic DNA and reconstructed complete IFNL4
cDNA sequences of chimpanzee (Genbank accession JX867772),
baboon (Genbank accession KC525947) and crab-eating macaque
(Genbank accession KC525948). The whole IFNL4 genomic
region is absent in mouse or rat. All discovered functional IFNL4
sequences (Table S8) where used for a multiple-sequence
alignment which was created using ClustalW [52] and annotated
with Jalview [53].
The alignment was analyzed with codeml (part of PAML4 [54])
to test various models of selection. We estimated the overall dN/
dS for the complete tree and compared likelihoods for models that
allowed: i) free dN/dS for each branch (i.e., lineage heterogeneity);
ii) a primate-specific dN/dS; and iii) a human-specific dN/dS.
Additionally, we performed tests aimed to detect site-specific
signatures of positive selection across the phylogeny (branch
models): i) model 1a (neutral) vs. model 2 (positive selection); ii)
model 7 (neutral) vs. model 8 (with dN/dS.1); and iii) model 8a
(with dN/dS= 1) vs. model 8 (with dN/dS.1).
Human population genetic data
We analyzed genome-wide data from the 1000 Genomes release
(2010/11/23; phase I) [24]. We considered (1) autosomal variants
detected in the low coverage sequencing, and (2) populations with
information for at least 50 unrelated individuals, which was met by
13 populations from four different continents [African ancestry:
YRI (Yoruba in Ibadan, Nigeria), LWK (Luhya in Webuye,
Kenya), ASW (African Ancestry in Southwest US); European
ancestry: GBR (British from England and Scotland), CEU (Utah
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residents (CEPH) with Northern and Western European ancestry),
FIN (Finnish from Finland), TSI (Toscani in Italia); East Asian
ancestry: CHS (Han Chinese South), CHB (Han Chinese in
Beijing, China), JPT (Japanese in Toyko, Japan); American
ancestry: MXL (Mexican Ancestry in Los Angeles, CA), CLM
(Colombian in Medellin, Colombia), PUR (Puerto Rican in Puerto
Rico)]. As an exception PUR (Puerto Rico) was analyzed although
it contains only 44 individuals. Some analyses were performed
both by population and by continent; in these cases the continental
groups contain 150 randomly selected, unrelated individuals
(America 144) with an equal contribution from each population
within the continent.
For the rs368234815 DG/TT frameshift-substitution variant
the 1000 Genomes dataset only contains the T insertion/deletion
variant rs11322783 (-/T, chr19:39739154, dbSNP b138), while
the substitution rs74597329 (G/T, chr19:39739155, dbSNP b138)
is absent. This is due to the automatic variant caller failing to
correctly identify an insertion and a substitution in the same
genomic position. We sequenced an amplicon containing
rs368234815 in 153 individuals included both in the 1000
Genomes and HapMap sets (CEU, YRI and CHB/JPT).
Sequencing confirmed the presence of only two alleles (DG and
TT) and showed good concordance with the 1000 Genomes data
between our DG/TT genotypes and 1000 Genomes genotypes for
the overlapping insertion/deletion variant rs11322783 (4 indivi-
duals of 153 tested were discordant, providing an estimated 97.4%
genotype and 98.7% allele concordance rate). This validated the
use of 1000 Genomes dataset for our subsequent analyses. We
used the ancestral allelic state annotated in the 1000 Genomes
data, which is based on the Ensembl 59 comparative 32 species
alignment [55]; only SNPs with a high-confidence ancestral
inference were used, and indels were excluded due to their cryptic
variation patterns [56].
Signatures of selection
We used FST, iHS and XP-EHH to explore the signatures of
selection of rs368234815 TT allele. FST is a measure of population
differentiation and unusually high FST can indicate population-
specific positive selection that drastically increases allele frequency
in the population under selection [57]. To calculate FST we used
the Weir and Cockerham [25] estimator implemented in vcf-tools
[58].
Positively selected alleles rapidly increase in frequency with
recombination having little chance to break their association with
nearby variants. If the selected allele was originally in few
haplotype backgrounds and it has not reached fixation, it will be
associated with extended haplotype homozygosity (EHH), a
pattern that will be absent for the non-selected allele. We used
two statistics to explore this expectation. First, iHS [27] measures
the allele-specific decay of EHH within a population by comparing
the associated EHH of ancestral and derived alleles. Second, XP-
EHH [26] that detects alleles that are under selection in one
population only, by comparing EHH patterns both among allelic
types and across populations; as such XP-EHH has higher power
to detect population-specific selection. Low frequency variants
break the EHH signal, so following [59] we considered only SNPs
with derived allele frequency e 5% for XP-EHH or minor allele
frequency e 5% for iHS. Local recombination rate estimates were
obtained from a combined recombination map based on HapMap
data [60] from Africa, European, and Asian populations. Both
statistics were standardized to a mean of zero and a standard
deviation of one; for iHS, scores were then binned by frequency
(1%) as previously suggested [27]. Correlation of FST with XP-
EHH (CHS vs. YRI) or iHS (CHS) was calculated for all variants
present in the respective dataset with Spearman’s rank correlation
test implemented in R [61].
We used each of these statistics to analyze every non-African
population; for between-population comparisons we used Yoruba
as background, unless noted otherwise. To assess the putative
effects of this choice of populations we repeated the analyses for
continental groups, for different background populations, and for
SNPs that have their lowest allele frequency in Yoruba. In all cases
the empirical P-values were obtained by comparing the score for
rs368234815 to the whole-genome empirical distribution of the
respective statistic. Since this is a hypothesis-driven analysis with a
single variant analyzed within a single locus, no multiple testing or
genome-wide corrections are needed.
We also applied tests that analyze the signatures of selection in
the IFNL4 genetic region (,2.5 kb). Here we show results for Fay
and Wu’s H test [28], which detects the excess of high-frequency
derived alleles expected after a recent sweep with recombination.
Significance was estimated using 10,000 standard neutral
coalescent simulations [62]. Because demography affects the SFS
and can cause spurious results if not properly accounted for, our
simulations are run under a demographic model which includes
inferred parameters for populations of African [63], European
[63], Asian [63] and American [64] ancestry. A custom made perl
program (Neutrality Test Pipeline) was used to calculate the
statistic and corresponding P-value.
ABC analysis
To infer the model of selection that best fits IFNL4 data and
estimate the timing and selection strength of the TT allele, we used
an Approximate Bayesian Computation (ABC) approach [22]. In
particular, we followed a published approach [23], which has been
previously shown to discriminate well between SDN, SSV and
neutrality (NTR) [23]. In brief, this approach is based on
performing a large number of simulations under different selection
Figure 4. Map of the IFNL locus with locations of relevant SNPs (from Table 2) and the inferred recombination hotspot based on
recombination rates from [60].
doi:10.1371/journal.pgen.1004681.g004
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models, with random parameters drawn from some probability
distribution (called the prior distribution). Real data and simula-
tions are compared based on summary statistics, and through a
rejection scheme the simulations that most closely resemble real
data help inform inferences about the best-fitting model. The
parameter values that generate these simulations are then used to
obtain the posterior distribution of each parameter, whose mean
and standard deviation are used to perform the parameter
inferences. We extended the method to consider more than one
population, since two-population statistics are most informative in
our case.
Specifically, the approach uses msms [65] to simulate data,
custom python scripts to calculate all summary statistics, and
ABCtoolbox [66] for all ABC inferences. Under both selection
Figure 5. (A) Graphical representation of the different models of selection tested in the ABC analysis (NTR - neutral, SDN - selection
on a de novo mutation, and SSV - selection on standing variation). We simulated one ancestral population that splits at the out-of-Africa
event (at 51,000 years ago) into the African (AFR) and the non-African (non-AFR) populations, which experience subsequent migration. The star
indicates the appearance of the focal mutation. In the first case the neutral (black) mutation appeared and evolved under neutrality in both
populations. In the SDN model the advantageous mutation (red) is immediately under positive selection with strength sA, and time when selection
started tmut (the prior parameter space for tmut is indicated by a green line); selection strength is allowed to change in the non-African population to
sNA. In the SSV model the neutral (black) mutation appeared and evolved under neutrality, becoming advantageous in the non-African population
(red line) at time tmut. Prior parameter spaces can be found in methods. (B) Posterior probabilities of the model choice for the different selection
models under perfect additivity. (C) Posterior probabilities of the model choice for the different dominance models (and neutrality, NTR). For all
models except NTR the posterior probability represent the sum for the SDN and SSV selection models. (D) Posterior probabilities of the model choice
for the different selection models under the supra-additive model. In (B), (C), and (D), NTR has negligible posterior probability and is therefore not
visible.
doi:10.1371/journal.pgen.1004681.g005
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models, we started with uniform priors with a range as follow (see
Fig. 5A):
(1) SDN model - selection strength in Africa sA,U(0,1.5%);
selection strength in non-Africa sNA,U(0.5,5%); time when
selection started tmut,U(40,70kya)
(2) SSV model - selection strength in non-Africa sNA,U(.0,5%);
frequency of the allele when selection started f0,U(0,20%);
time when selection started tmut,U(21,51kya)
(3) NTR model - time when mutation appears t,U(40,70kya)
Because simulations with the selected allele fixed are likely to be
very different from the observed data, we conditioned on the
selected allele segregating in both populations. This resulted in
non-uniform prior distributions presented in Figure S5 and S6. We
used 104 simulations to distinguish between the neutral model and
the two selection models, and a larger set of 86105 simulations for
the more subtle distinction between the two selection models and
for parameter estimation. For the simulations, we used the
population history model estimated by Gravel et al. [63] and
assumed a constant recombination rate of 1.76 cm/Mb through-
out the region (average recombination rate in the IFNL locus
[60]), and a perfectly additive model of dominance (h = 0.5). Lack
of an appropriate demographic model for American and non-
Yoruba African populations precludes analysis for those popula-
tions. The following single-population statistics were calculated:
the average number of pairwise differences p, Watterson’s h, Fay
and Wu’s H [28] and Tajima’s D [67], all for both 4 kb around
the site and a 8 kb (6 kb upstream and 2 kb downstream of the
site) interval around the TT allele. The between-population
statistics employed were: FST [68] for the selected site, FST in 4 kb
around the site, FST for the whole region, and XP-EHH on the
selected site [26]. In addition, we also included the frequency of
the selected allele in both populations. This resulted in a set of 16
summary statistics, which, following Wegmann et al. [69] and
Peter et al. [23], was reduced to seven summary statistics using
PLS-DA [70] for model choice and regular PLS for parameter
inference [71]. Performance of the ABC model choice and
parameter distribution for the SDN model has been assessed for
each particular model (Note S3). Confidence in the choice of
selection models has been supported with Bayes factors.
In addition, we investigated the influence of the dominance
model in our inferences. We analyzed a recessive model for TT
(h = 0), the perfectly additive model above (h = 0.5), and a supra-
additive model (h = 0.38), using 500,000 simulations for each
model. We run an ABC analysis for model selection with all
simulations (from all three dominance models and the three
selection models NTR, SDN, and SSV). We then assess the
posterior probability of each dominance model regardless of
selection model, and the posterior probability (and parameter
estimates) of each selection model for the additive and supra-
additive dominance models (see Note S4).
URLs
1000 Genomes, ftp://ftp.1000genomes.ebi.ac.uk/vol1/ftp/
phase1/; GENCODE, http://pseudogene.org/psidr/; HapMap,
http://hapmap.ncbi.nlm.nih.gov; XP-EHH and iHS executables,
http://hgdp.uchicago.edu/Software/; VCFtools, http://vcftools.
sourceforge.net; ABCtoolbox: http://www.cmpg.iee.unibe.ch/
content/softwares__services/computer_programs/abctoolbox/index_
eng.html; msms: http://www.mabs.at/ewing/msms/
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P: posterior probability, tmut: time when selection started (based on a generation time of 25 yr), SA: selection coefficient in Africa (YRI), SNA: selection coefficient in the
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